article thumbnail

Evaluating the potential for psilocybin as a treatment for post-traumatic stress disorder [Minireview]

ASPET

In most patients, currently available pharmacological and psychological treatments are insufficient to alleviate the array of symptoms associated with the disorder. Thus, novel treatment options that can more effectively target the core etiology of PTSD are desperately needed.

Treatment 189
article thumbnail

At-Home Brain Stimulation Treatment Can Safely Ease Depression

Drugs.com

22, 2024 -- At-home brain stimulation therapy can safely and effectively treat severe to moderate depression, a new clinical trial shows.Rates of treatment response and depression remission were three times higher in people receiving. TUESDAY, Oct.

Treatment 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Treatment Could Be New Option for People Battling Ulcerative Colitis

Drugs.com

27, 2024 -- An experimental monoclonal antibody treatment appears to ease the digestive disorder ulcerative colitis in patients who've failed other medications, a new trial shows.The treatment, tulisokibart, spurred remission of. FRIDAY, Sept.

Treatment 111
article thumbnail

Lymphoma: Know Your Treatment Options

Drugs.com

THURSDAY, May 16, 2024 -- For anyone newly diagnosed with blood cancers known as lymphomas, their first question might be: What treatments can help?Of Of course, there have been big advances in chemotherapy against the disease, but treatments now go.

Treatment 111
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

Key Learning Objectives: Enhance Patient Communication 📲 Explore how AI facilitates more personalized, timely, and efficient patient interactions, improving overall engagement and satisfaction Leverage AI for Improved Patient Care & Predictive Medicine 🧬 Learn how AI helps healthcare providers offer more precise, preventive care by (..)

article thumbnail

Why Treatments Can Fail Folks With 'Wet' Macular Degeneration -- and What Might Really Work

Drugs.com

5, 2024 -- Current treatments sometimes fail to help people with “wet” age-related macular degeneration -- and researchers now think they know why.Wet AMD is caused by an overgrowth of blood vessels in the retina, the light-sensing tis. TUESDAY, Nov.

Treatment 108
article thumbnail

Preclinical Evaluation of MK-8189: A Novel Phosphodiesterase 10A Inhibitor for the Treatment of Schizophrenia [Neuropharmacology]

ASPET

MK-8189 is a novel phosphodiesterase 10A (PDE10A) inhibitor being evaluated in clinical studies for the treatment of schizophrenia. Significance Statement We describe the primary pharmacology of MK-8189 a PDE10A inhibitor under evaluation for the treatment of schizophrenia.

Treatment 100